Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), breaks down the reasoning behind the organization's decision to add Bayer's Kerendia (finerenon) as a recommended drug for kidney disease prevention.
Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), breaks down the reasoning behind the organization's decision to add Bayer's Kerendia (finerenone) as a recommended drug for kidney disease prevention.
Transcript
What went into the ADA’s decision to add a recommendation for the use of Bayer’s Kerendia (finerenone) for preventing CKD progression and cardiovascular events?
Each year, as we develop the standards of care, we review all of the scientific and medical literature the year before. One of the things that really jumped out was the availability of new treatments to prevent progression of chronic kidney disease and congestive heart failure. Finerenone, a newly approved drug, has had some wonderful evidence and randomized controlled trials to do both of those things. And it was important that we update the standards so that clinicians could understand how they could use this new treatment modality.
More Needs to Be Done to Reduce Racial Disparities in Home Dialysis
March 24th 2023On this episode of Managed Care Cast, we speak with Virginia Wang, PhD, and Matthew L. Maciejewski, PhD, who talk about their recent study on racial disparities in home dialysis, and what more needs to be done to increase uptake and reduce disparities in home dialysis for non-White patients.
Listen
Advocating for All Patients With Chronic Kidney Disease
April 26th 2022Chronic kidney disease is the fastest-growing noncontagious disease in the United States. On this episode of Managed Care Cast, we speak with Mike Spigler, vice president of patient support and education for the American Kidney Fund, who is spearheading the Unknown Causes of Kidney Disease Project, which aims to help underserved patients get to the root cause of their kidney disease, while also helping to solve this mystery for a broader patient population.
Listen